Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01615497
Other study ID # 1204010157
Secondary ID R21AA021405-01
Status Completed
Phase N/A
First received
Last updated
Start date November 2012
Est. completion date June 2015

Study information

Verified date March 2020
Source Yale University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators are conducting a randomized clinical trial of our new web-based version of the CBT4CBT (Computer Based Training for Cognitive Behavioral Therapy) program specifically designed for alcohol to evaluate its effectiveness relative to standard outpatient counseling at the Substance Abuse Treatment Unit (SATU). The computer-based training program (CBT4CBT) focuses on teaching basic coping skills, presenting examples of effective use of coping skills in a number of realistic situations in video form, and providing opportunities for patients to practice and review new skills while receiving substance abuse treatment.


Description:

Ninety alcohol using individuals seeking treatment at the Substance Abuse Treatment Unit (SATU) of the Connecticut Mental Health Center will be randomized to (1) standard outpatient counseling at SATU (typically consisting of weekly group counseling), (2) standard outpatient counseling plus web-based CBT, or (3) web-based CBT4CBT with minimal clinical monitoring. Treatments will be delivered over an 8-week period with a six-month follow-up after termination of the study treatments. The primary outcome measures will be reduction in alcohol use (frequency of alcohol use by time, confirmed by urine toxicology screens and breathalyzers). Secondary outcomes will include treatment utilization and cost, several measures intended to detect whether web-based CBT4CBT retains key characteristics of traditional clinician-administered CBT (e.g., acquisition of coping skills, use of change strategies), participant characteristics which will be evaluated as potential moderators of outcome, as well as participant satisfaction and treatment credibility.


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date June 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Are 18 years of age or older.

- Are applying for outpatient, non-agonist substance abuse treatment at SATU.

- Meet current DSM-IV criteria for alcohol abuse or dependence.

- Are sufficiently stable for 8 weeks of outpatient treatment.

- Can commit to 8 weeks of treatment and are willing to be randomized to treatment

- Are willing to provide locator information for follow-up.

- Are fluent in English and have a 6th grader or higher reading level

Exclusion Criteria:

- Have an untreated bipolar or schizophrenic disorder.

- Who have a current legal case pending such that incarceration during 8-week protocol is likely.

- Are physically dependent on alcohol, opioids or benzodiazepines

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Standard Treatment as Usual (TAU)
Treatment normally offered at this clinic which could include individual or group alcohol and drug counseling sessions one time per week lasting one hour each time.
Web-based CBT4CBT for alcohol plus TAU
Subjects work with a computerized program that teaches skills for stopping alcohol and drug use and increasing coping skills. Computerized sessions are one time per week and last about one hour per session. Plus TAU
Web-based CBT with minimal clinical contact
Subjects work with a computerized program that teaches skills for stopping alcohol and drug use and increasing coping skills. Computerized sessions are one time per week and last about one hour per session. Plus 10 minute check in with clinician.

Locations

Country Name City State
United States Substance Abuse Treatment Unit (SATU) New Haven Connecticut
United States Substance Abuse Treatment Unit (SATU) New Haven Connecticut

Sponsors (3)

Lead Sponsor Collaborator
Yale University National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reduction in alcohol use 8 weeks
Secondary Subjects ability to demonstrate coping skills through a computerized role-playing evaluation and homework 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT03892369 - FGF21 and Its Role in Alcohol Dependence N/A
Active, not recruiting NCT05281172 - Guided Self-Change Prevention Program for Alcohol Abuse in Adolescents in Educational Settings N/A
Recruiting NCT03848000 - Examination of Whether an Exercise Programme Reduces Alcohol Consumption Among Alcohol-Dependent Adults N/A
Terminated NCT04094584 - Emergency Department Initiated Extended-Release Naltrexone and Case Management for the Treatment of Alcohol Use Disorder Phase 4